Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,317 | 20,611 | -108,621 | -76,538 | -43,086 |
| Depreciation Amortization | 14,470 | 7,064 | 24,905 | 18,135 | 11,563 |
| Accounts receivable | 1,686 | 1,974 | 3,064 | 7,365 | 2,210 |
| Accounts payable and accrued liabilities | -5,500 | -5,069 | 4,770 | 543 | -1,864 |
| Other Working Capital | 28,694 | -9,929 | 16,095 | -9,737 | -16,677 |
| Other Operating Activity | -60,423 | -64,723 | -19,752 | -5,831 | 1,405 |
| Operating Cash Flow | $-90,390 | $-50,072 | $-79,539 | $-66,063 | $-46,449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,470 | -6,728 | -38,875 | -30,657 | -18,258 |
| Purchase Of Investment | -330,406 | -165,211 | -702,885 | -596,966 | -476,363 |
| Sale Of Investment | 356,568 | 191,163 | 727,582 | 600,837 | 472,057 |
| Other Investing Activity | 92,968 | 92,612 | -1,784 | -378 | -219 |
| Investing Cash Flow | $103,660 | $111,836 | $-15,962 | $-27,164 | $-22,783 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,500 | 8,500 | 5,000 | N/A | N/A |
| Debt Repayment | -1,218 | -667 | -3,986 | -3,340 | -2,356 |
| Common Stock Issued | 4,532 | 3,177 | 13,327 | 10,534 | 7,389 |
| Other Financing Activity | 0 | 0 | -499 | 0 | 0 |
| Financing Cash Flow | $11,814 | $11,010 | $13,842 | $7,194 | $5,033 |
| Exchange Rate Effect | 228 | -99 | 552 | 422 | 262 |
| Beginning Cash Position | 108,098 | 108,098 | 189,205 | 189,205 | 189,205 |
| End Cash Position | 133,410 | 180,773 | 108,098 | 103,594 | 125,268 |
| Net Cash Flow | $25,312 | $72,675 | $-81,107 | $-85,611 | $-63,937 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,390 | -50,072 | -79,539 | -66,063 | -46,449 |
| Capital Expenditure | -14,651 | -6,728 | -38,875 | -30,657 | -18,258 |
| Free Cash Flow | -105,041 | -56,800 | -118,414 | -96,720 | -64,707 |